US 2024/0327446 A1 · DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF

Abstract

A series of deuterated nucleoside compounds are compounds represented by formula (IV), and stereoisomers or pharmaceutically acceptable salts thereof.

Claims2

Dependent claims

1-10. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

18/682,091Filed 17 May 2023

Priority

CN 202210548373.717 May 2022

Published

3 Oct 2024

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61P 31/14
Antivirals: for RNA viruses
C07D 487/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…
A61K 31/706
Having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides: containing six-membered rings with nitrogen as a ring hetero atom

Abstract

A series of deuterated nucleoside compounds are compounds represented by formula (IV), and stereoisomers or pharmaceutically acceptable salts thereof.

Deuterated nucleoside compounds and use thereof

Life of this patent

Abstract

Claims2

Deuterated nucleoside compounds and use thereof

Life of this patent

Abstract

Claims2